Tonix Pharmaceuticals Holding Corp. (TNXP)
13.59
+0.03
(+0.22%)
USD |
NASDAQ |
Aug 28, 16:00
13.56
-0.02
(-0.18%)
After-Hours: 20:00
Tonix Pharmaceuticals Market Cap : 228.21M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 228.21M |
| August 27, 2026 | 227.70M |
| August 26, 2026 | 229.05M |
| August 25, 2026 | 229.38M |
| August 24, 2026 | 209.06M |
| August 21, 2026 | 210.74M |
| August 20, 2026 | 208.06M |
| August 19, 2026 | 213.77M |
| August 18, 2026 | 212.59M |
| August 17, 2026 | 212.59M |
| August 14, 2026 | 213.43M |
| August 13, 2026 | 209.90M |
| August 12, 2026 | 201.00M |
| August 11, 2026 | 207.22M |
| August 10, 2026 | 211.42M |
| August 07, 2026 | 202.01M |
| August 06, 2026 | 195.63M |
| August 05, 2026 | 189.08M |
| August 04, 2026 | 159.24M |
| August 03, 2026 | 151.50M |
| July 31, 2026 | 142.20M |
| July 30, 2026 | 143.33M |
| July 29, 2026 | 135.09M |
| July 28, 2026 | 141.20M |
| July 27, 2026 | 147.31M |
| Date | Value |
|---|---|
| July 24, 2026 | 140.35M |
| July 23, 2026 | 150.86M |
| July 22, 2026 | 150.44M |
| July 21, 2026 | 164.21M |
| July 20, 2026 | 155.98M |
| July 17, 2026 | 176.57M |
| July 16, 2026 | 168.33M |
| July 15, 2026 | 164.92M |
| July 14, 2026 | 157.11M |
| July 13, 2026 | 166.27M |
| July 10, 2026 | 177.99M |
| July 09, 2026 | 185.10M |
| July 08, 2026 | 181.54M |
| July 07, 2026 | 180.55M |
| July 06, 2026 | 180.55M |
| July 02, 2026 | 175.29M |
| July 01, 2026 | 176.72M |
| June 30, 2026 | 181.26M |
| June 29, 2026 | 181.12M |
| June 26, 2026 | 187.80M |
| June 25, 2026 | 170.18M |
| June 24, 2026 | 171.89M |
| June 23, 2026 | 169.90M |
| June 22, 2026 | 173.31M |
| June 18, 2026 | 170.61M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Exelixis, Inc. | 13.55B |
| Inovio Pharmaceuticals, Inc. | 106.22M |
| Heron Therapeutics, Inc. | 61.88M |
| ACADIA Pharmaceuticals, Inc. | 5.011B |
| Alnylam Pharmaceuticals, Inc. | 31.71B |
Market Cap Related Metrics
| PS Ratio | 5.962 |
| Price to Book Value | 1.027 |
| Price | 13.59 |
| Earnings Yield | -95.17% |